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Abstract
Objective—Benign epilepsy with centrotemporal spikes (BECTS), the most common focal 
childhood epilepsy, is associated with subtle abnormalities in cognition and possible 
developmental alterations in brain structure when compared to healthy participants as indicated by 
previous cross-sectional studies. To examine the natural history of BECTS, we investigated 
cognition, cortical thickness, and subcortical volumes in children with new/recent onset BECTS 
and healthy controls (HC).
Methods—Participants were 8–15 years of age, including 24 children with new onset BECTS 
and 41 age- and gender-matched HC. At baseline and two years later, all participants completed a 
cognitive assessment and a subset (13 BECTS, 24 HC) underwent T1 volumetric MRI scans 
focusing on cortical thickness and subcortical volumes.
Results—Baseline cognitive abnormalities associated with BECTS (object naming, verbal 
learning, arithmetic computation, psychomotor speed/dexterity) persisted over two years, with the 
rate of cognitive development paralleling that of HC. Baseline neuroimaging revealed thinner 
cortex in BECTS compared to controls in frontal, temporal, and occipital regions. Longitudinally, 
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HC showed widespread cortical thinning in both hemispheres, while BECTS participants showed 
sparse regions of both cortical thinning and thickening. Analyses of subcortical volumes showed 
larger left and right putamens persisting over two years in BECTS compared to HC.
Significance—Cognitive and structural brain abnormalities associated with BECTS are present 
at onset and persist (cognition) and/or evolve (brain structure) over time. Atypical maturation of 
cortical thickness antecedent to BECTS onset results in early-identified abnormalities that further 
continue to abnormally develop over time. However, cognition appears more resistant to further 
change over time compared to anatomical development.
Keywords
Benign epilepsy with centrotemporal spikes (BECTS); cortical thickness; pediatric development; 
neuropsychological assessment
INTRODUCTION
Benign epilepsy with centrotemporal spikes (BECTS) is the most common localization-
related epilepsy syndrome in children1. While the name of this epilepsy syndrome suggests a 
benign course, there is now substantial evidence documenting that cognitive and academic 
problems complicate the lives of children with BECTS2–6, challenging the “benign” nature 
of the syndrome.
Subtle MRI cortical abnormalities in the frontal, temporal, perisylvian and parietal regions 
have been demonstrated in children with established BECTS7–8, although studies in new-
onset BECTS have not been performed. Anomalies in the volume and shape of subcortical 
structures including the putamen have also been reported9. Similarly, cognitive disturbances 
including abnormalities in language, verbal learning, attention, and executive function have 
been reported in BECTS. How these neuroanatomical and cognitive abnormalities arise and 
progress from the time of epilepsy onset have not been investigated and is the focus of the 
present study. Specifically, we aimed to uncover the changes imposed by epilepsy on normal 
brain and cognitive development during the first two years after epilepsy diagnosis.
This study is a prospective examination of the trajectory of cognitive and brain development 
in a cohort of children with new-onset BECTS over the first two years after diagnosis. First, 
we investigate the cognitive trajectories in language, academic, verbal learning, motor, and 
psychomotor processing speed and determine whether cognitive impairment is static or 
progressive over the first two years after diagnosis. Second, we compare brain structural 
development in children with new-onset BECTS to age- and gender-matched typically 
developing children. Specifically, we investigate potential differences in the developmental 
trajectory of cortical thickness and putaminal volumes in children with BECTS compared to 
healthy controls
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METHODS
Participants
Study participants include 24 children with new-/recent-onset BECTS and 41 healthy first-
degree cousin controls matched for age and gender while blinded to MRIs. All participants 
completed comprehensive cognitive assessment (see below) while a subset (13 BECTS, 24 
matched HC) also underwent T1 volumetric MRI scans. MRI scans for other participants 
could not be used because of excessive motion, susceptibility artifacts caused by orthodontic 
braces, claustrophobia, and other reasons. Children were recruited from pediatric neurology 
clinics at three medical centers (University of Wisconsin, Madison, WI; Marshfield Clinic, 
Marchsfield, WI; Dean Clinic, Madison, WI) and met the following inclusion criteria: (i) 
diagnosis of epilepsy within the past 12 months; (ii) no other developmental disabilities (e.g. 
intellectual impairment, autism); (iii) no other neurological disorder, and (iv) normal clinical 
MRI. A pediatric neurologist certified by the American Board of Psychiatry and Neurology 
diagnosed individuals with BECTS according to the ILAE international classification of 
epilepsy10. Specifically, all children with BECTS demonstrated: 1) the presence of tonic–
clonic nocturnal seizures or simple partial seizures during waking hours, 2) centrotemporal 
spikes on EEG occurring independently in the right and/or left hemispheres, and 3) normal 
EEG background. Participants demonstrating epileptiform activity outside the rolandic area 
were not included in the study. We did not exclude children on the basis of psychiatric 
comorbidities (including ADHD) or learning disabilities. We did however exclude children 
with intellectual disabilities, autism, or other neurological disorders. All children with 
epilepsy were attending regular schools at the time of baseline evaluations and IQ was 
within normal levels.
The children with epilepsy were recruited from the practices of 8 child neurologists across 
three institutions. Each child’s epilepsy syndrome was reviewed and confirmed in a research 
consensus meeting by the research pediatric neurologist who reviewed all available clinical 
data (e.g., seizure description and phenomenology, EEG, clinical imaging, 
neurodevelopmental history) while blinded to all research cognitive, behavioral, and 
neuroimaging data.
Criteria for inclusion of control participants include no neurological disorders, no history of 
seizures, no history of any classic precipitating injury (e.g., febrile seizures), no previous 
loss of consciousness for more than 5 minutes, and no other family history of a first-degree 
relative with epilepsy or febrile convulsions. Further details and rationale for selection 
criteria for participants can be found in previous publications11. Details regarding 
demographic and clinical characteristics of the study participants are provided in Table 1. 
All patients and controls were seen at baseline and two years later and all procedures were 
conducted by research staff.
The project protocol was reviewed and approved by the institutional review board of the 
University of Wisconsin School of Medicine and Public Health. Families and children gave 
written informed consent or assent, respectively, on the day of the study.
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Clinical assessments
In children with BECTS, the attending child neurologist recorded their seizure frequency 
and antiepileptic medication use over the course of two years from diagnosis. If changes in 
seizure frequency or antiepileptic medication were discovered during the research interview, 
this information was related to the treating neurologist and the record was adjusted. Seizure 
remission or seizure-free status was defined as a cessation of seizures for 12 months or more 
and termination of AED use. Seizure severity was measured with the Liverpool Seizure 
Severity Scale for Children in those participants with active seizures (at least 1 seizure in 
past year). The scale is based on the adult version12 and consists of 10 questions with good 
internal consistency (r= 0.71–0.84) and test–retest correlation (r= 0.67–0.84)13.
Neuropsychological assessment
At baseline and two-year follow-up, all participants were administered a comprehensive 
neuropsychological test battery that included measures of intelligence, academic 
achievement, language, verbal memory, motor function, attention and executive function. 
We previously reported14 that, at baseline, children with BECTS exhibited significantly 
poorer performance compared to controls on measures of immediate and delayed verbal 
memory (Children’s Memory Scale [CMS])15, motor function (Grooved Pegboard--
dominant hand16; and Wechsler Intelligence Scale for Children-III [WISC-III] Digit Symbol
—Coding)17, confrontation naming (Boston Naming Test [BNT])18 and arithmetic ability 
(Wide Range Achievement Test-3 [WRAT-3])19. In the current study, we focused on change 
in age and gender adjusted raw scores over time for each of these 6 measures using a 2 
(Group: BECTS vs HC) × 2 (Time: Baseline vs Follow-up) mixed repeated measure 
ANCOVA design, with age and sex as covariates.
MRI acquisition
MR images were obtained on a 1.5-T GE Signa MRI scanner (GE Healthcare, Waukesha, 
WI, USA). T1-weighted images were acquired using a three-dimensional (3D) spoiled 
gradient recall (SPGR). The imaging parameters were: TE = 5 ms, TR = 24 ms, flip angle = 
40°, NEX = 1, slices = 124, slice thickness = 1.5 mm, plane = coronal, field of view (FOV) 
= 200 mm, matrix = 256 × 256.
MRI processing and cortical thickness mapping
MR Images were processed with the FreeSurfer image analysis suite (version 5.1). The T1-
weighted MR images were used for cortical reconstruction and volumetric segmentation. 
The technical details of these procedures include motion correction and averaging, removal 
of non-brain tissue20, automated Tailarach transformation21, segmentation of the subcortical 
white matter and deep gray matter volumetric structures22 (e.g. hippocampus, amygdala, 
caudate, putamen, ventricles), intensity normalization, tessellation of the gray matter white 
matter boundary, automated topology correction23, and surface deformation following 
intensity gradients to effectively place the boundaries between brain tissue (CSF, WM and 
GM)24. This software calculates thickness as the closest distance from the gray matter–white 
matter boundary to the gray matter–CSF boundary at each vertex on the tessellated 
surface24. All data were processed with the longitudinal stream in FreeSurfer25. This stream 
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is designed to be unbiased with respect to any time point by creating a within-subject 
template volume (base image). In this way, reliability and statistical power are significantly 
increased25. All data were visually inspected for quality assurance.
Cortical thickness analysis
Cross-sectional analysis of cortical thickness differences at baseline as well as longitudinal 
change in cortical thickness was investigated between groups. These analyses were 
undertaken using FreeSurfer’s statistical tool, Qdec. Data were smoothed with a 15-mm full-
width half-maximum (FWHM) to improve inter-subject variability. To correct for multiple 
comparisons, a Qdec Monte Carlo simulation was implemented with cluster-forming 
threshold set to p<0.05. In order to evaluate prospective neuroanatomical changes in a more 
accurate way, baseline differences in cortical thickness were controlled for in the analysis. 
All analyses were corrected for age and gender.
Volumetric analysis
Volume of the putamen was obtained from the FreeSurfer automated segmentation 
processing stream was analyzed with the software package SPSS. A multivariate analysis of 
covariance (MANCOVA) was performed examining group differences with age, gender and 
intracranial volume (ICV) included as covariates. Differences were considered significant at 
p<0.05.
RESULTS
Cognition
Table 1 shows the clinical characteristics of the BECTS group, including use of anti-
epilepsy medications, duration of epilepsy, age of onset, and seizure free status at follow-up. 
Ten of the 24 children with BECTS were seizure free and not taking anti-seizure 
medications (42%) at follow-up assessment. Seizure-free BECTS were not significantly 
different than non-seizure-free BECTS in age, gender, education, number of AEDs, and 
syndrome duration. However, seizure-free children with BECTS had higher baseline IQ 
scores and socioeconomic status (reflected in parental education) compared to non-seizure 
free children with BECTS. Cognitive test scores at both time points showed no differences 
as a function of remission status; thus, all BECTS participants were used in the following 
analyses.
After correcting for multiple comparisons (six tests), main effects for Time (Baseline, 
Follow-up) was found for arithmetic (WRAT-3: F[1,61]=60.088, p<0.001) where 
performance was better at two-year follow-up compared to baseline. Main effects for Group 
(BECTS, HC) were found for immediate verbal memory (CMS: F[1,61]=8.458, p=0.005), 
confrontation naming (BNT: F[1,61]=8.215, p=0.006), and both motor function tasks 
(Grooved Pegboard: F[1,61]=14.015, p<0.001; WISC-III Coding: F[1,77]=13.379, 
p=0.001). In all cases, control participants performed better than children with BECTS at 
both baseline and follow-up (Figure 1) with prospective improvement present in both 
BECTS and control groups although not significant (no main effects for Time). The lack of 
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significant effects for Time could be related to the small number of participants in the study. 
There was no Group x Time interaction for any of the measures.
To investigate whether seizure severity has an impact on cognition at the baseline 
evaluation, the association between seizure severity and baseline scores for each of the six 
neuropsychological tests was evaluated. The arithmetic test was the only variable associated 
with seizure severity (R=−0.458, p=0.024, uncorrected for multiple comparisons).
Baseline and prospective cortical thickness
Whole brain vertex-wise analyses of cortical thickness and thickness rate of change were 
obtained for both groups at baseline (near the time of epilepsy diagnosis) and prospectively 
two years later. Compared to control participants, children with BECTS presented regions of 
thinner cortex at baseline (Figure 2) including bilateral rostral middle frontal gyrus 
(p<0.005), right inferior frontal gyrus (p<0.01), left inferior temporal gyrus (p<0.05), left 
lateral occipital (p<0.001), and right cuneus (p<0.005). In terms of millimeter changes the 
average of these differences was 0.13mm lower in BECTS. Note that these p-values are 
corrected for multiple comparison errors.
There is considerable evidence that the baseline anatomical characteristics may influence the 
rate of brain developmental changes26. Given that anatomical differences at baseline exist 
between BECTS and controls (Figure 2), subsequent analyses of prospective 
neurodevelopmental changes were controlled for baseline difference in cortical thickness. 
Figure 3 showed changes in cortical thickness over the two years after the diagnosis of 
BECTS and demonstrated a small region of cortical thinning in the left isthmus cingulate 
(p=0.020) and a region of cortical thickening in the right precentral gyrus (p=0.025) (Figure 
3A), while control participants showed widespread cortical thinning in both hemispheres 
(p<0.001) (Figure 3B). Over the two years following epilepsy diagnosis, children with 
BECTS displayed less cortical thinning bilaterally, relative to controls (Figure 4). 
Specifically, less cortical thinning was observed in the left rostral middle frontal gyrus 
(p<0.001), left insula (p=0.01), bilateral occipital gyrus (p<0.001), bilateral postcentral 
gyrus (p<0.002), and right superior frontal gyrus (p<0.001). These p-values are cluster-
corrected for multiple comparisons. To examine the possible effects of seizure frequency 
status at follow-up, we compared prospective cortical thickness developmental differences 
between children seizure free for at least one year versus individuals who continued to have 
seizures. Only one significant cluster was found - right pars opercularis (Talairach 
coordinates: 40.9, 20.3, 8.2) - in which seizure-free participants had greater thinning 
compared to the non-remitted subgroup (see figure 1S in supplemental document). Note that 
this cluster does not overlap with any of the clusters found in the prospective analyses 
presented above.
Putamen volume
A main effect of Time (Baseline, Follow-up) was found for right putamen (F[1,32]=5.335, 
p=0.028), which represented a reduction in volume over time. Main effects of Group 
(BECTS, HC) were found for left putamen (F[1,32]=7.574, p=0.010) and right putamen 
(F[1,32]=6.279, p=0.017). In both cases, children with BECTS had increased putaminal 
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volumes compared to HC. No significant Group x Time interactions were found for either 
left or right putamen. Putamen size at both time points (mm3) can be found in table S1 in 
supplemental document.
To determine whether differences in putamen volume could be attributed to seizure-
remission status in the group of BECTS, the same analysis was performed between remitted 
and non-remitted BECTS, with no significant main effects found for either Time or Group; 
likewise, there were no significant Group x Time interactions.
DISCUSSION
This study investigated both baseline and prospective changes in cognition and brain 
development (cortical thickness and subcortical volumes) in children with new/recent-onset 
BECTS, providing a comprehensive and dynamic characterization of cognitive and brain 
maturation early in the course of the disease. Moreover, we demonstrate that brain 
development is differentially modulated by age in BECTS and controls. Previous cross-
sectional neuroimaging studies have demonstrated both thinner7 and thicker8 regions of the 
perisylvian cortex in BECTS compared to controls. As the dynamics of brain development 
are better estimated from changes over time rather than at a single time point, the timing of 
imaging in the context of the developing brain may contribute to these discrepant findings in 
cross-sectional studies.
The core findings can be summarized as follows. First, children with BECTS showed 
cognitive abnormalities at baseline that persisted in an unchanged fashion over the two years 
following epilepsy diagnosis. Both the HC and BECTS groups exhibited cognitive 
development over the two-year period, but the BECTS group continued to perform below 
controls in a static fashion. Second, at the time of diagnosis, children with BECTS exhibited 
regions of thinner cortex in the frontal, temporal, and occipital lobes. Third, over the two 
years after epilepsy diagnosis, children with BECTS demonstrated restricted regions of both 
cortical thinning and thickening, while the control group showed the expected pattern of 
widespread cortical thinning. When contrasting developmental trajectory between the 
groups, the attenuation of age-related thinning in BECTS was evident in the frontal, parietal, 
temporal, occipital and insular cortices. Finally, children with BECTS demonstrated atypical 
baseline and prospective volumetric changes in the putamen.
Cognition
This study demonstrates how baseline cognitive deficits in children with BECTS evolve 
over the first two years after epilepsy diagnosis. At baseline, children with BECTS perform 
significantly worse than controls across tasks of expressive language, verbal learning 
efficiency, motor and psychomotor speed and dexterity (Figure 1). These cognitive deficits 
show good consistency with existing cross-sectional studies, with abnormalities spanning 
multiple cognitive domains27–28. Importantly, over time, both groups showed parallel age-
related cognitive development (i.e., increased raw scores over time), but the children with 
BECTS remained significantly below controls across most of the tested domains at the two-
year follow-up point. Thus, like controls, children with BECTS exhibited developmental 
Garcia-Ramos et al. Page 7
Epilepsia. Author manuscript; available in PMC 2016 October 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
improvement over time but retained the baseline performance deficits compared to controls, 
representing fixed cognitive differences.
This cognitive trajectory has been observed in different childhood epilepsies. Utilizing both 
broad classification of localization-related and idiopathic generalized epilepsies29 as well as 
syndrome-based diagnoses of juvenile myoclonic epilepsy (JME)30 and BECTS, we found 
that cognitive differences were evident at or near the time of diagnosis with generally stable 
performance over a 2-year period of follow-up. Thus cognitive abilities are adversely 
affected by diverse childhood epilepsies, which is surprising given their unique 
pathophysiologies. Further, control of seizures during the two-year interval did not influence 
the two-year cognitive course. Collectively, these findings question the longstanding view 
that cognitive complications associated with childhood onset epilepsies are largely due to 
chronicity of the seizures and medication effects. Indeed, our findings provide support for 
the persistence of an antecedent contribution to their cognitive deficits with little modifying 
impact from on-going disease during the first two years after diagnosis. How cognition will 
develop further with increasing age remains to be determined. The possibilities include static 
differences maintained over time going well beyond the presence of active seizures or 
improvement of cognition upon remission of the active phase of BECTS. Further 
prospective investigation will help to sort out these and other possibilities (e.g., 
normalization of some but not all abilities).
Brain Development
Our findings illustrate the dynamics of cortical development in BECTS, highlighting both 
baseline abnormalities and altered neurodevelopment over the first two years of this epilepsy 
syndrome. At baseline, thinner bilateral superior frontal, right inferior frontal, left inferior 
temporal, and bilateral occipital cortices were evident in brains of children with BECTS. 
Over two years, the brain developmental trajectory of BECTS diverged mostly in opposing 
directions from the control group. Remarkably, children with BECTS showed only a small 
region of age-related cortical thinning and another region of greater thickness over time 
(Figure 3A), indicating an abnormal trajectory of brain structural development.
In addition to cortical development, we also uncovered the persistence of abnormal 
subcortical development. In our previous cross-sectional study, we compared caudate, 
putamen, pallidum, and thalamus volumes between BECTS and controls. Among the basal 
ganglia structures, putamen was selectively hypertrophied in BECTS9. A recent study using 
FreeSurfer to examine cortical and subcortical structures in newly diagnosed BECTS also 
reported selective putamen hypertrophy31. Given the growing evidence for putamen 
anomaly in newly BECTS and in an effort to reduce the number of comparisons, we elected 
to focus on putamen and examine its prospective change in this study. Thus, we extend these 
cross-sectional findings by demonstrating that putamen volumes remain greater than 
controls over the first two years of the disease.
The functional implication of these brain structural changes in children with BECTS is 
unknown. Abnormal neurodevelopment in the dorsolateral prefrontal cortex, insular, 
precentral and parietal regions are highlighted in our study. We speculate that these cortical 
regions might be important for the development of language and executive function in 
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children. For example, the left insula and bilateral middle/superior frontal gyrus have been 
implicated in language function in typically developing children and children with 
BECTS2, 32–35. The essential role of prefrontal cortex in attention and executive function is 
well established36 and executive function deficit, a common comorbidity in BECTS37–38, 
has been related to abnormal fronto-occipital white matter connectivity39. We note that these 
structural-functional associations remain tentative and future studies are needed to target this 
question.
Limitations of the study—There are limitations in our study. First we only assessed gray 
matter changes in our cohort and future studies using diffusion tensor imaging will provide a 
more comprehensive analysis of brain maturation in BECTS. Second, we did not perform 
quantitative EEG analysis in children with BECTS and the burden of EEG abnormalities 
may contribute to cognitive deficits in this group of children (for a review see 40). However, 
it is unlikely that disease severity influence our findings, as seizure remission status did not 
drive our results.
CONCLUSION
Children with BECTS display a complex pattern of abnormal maturational processes. 
Cognitive and brain alterations are present at or near onset of seizures, suggesting that 
dysmaturational changes occurred temporally prior to the diagnosis of epilepsy. 
Furthermore, cognitive development proceeds in both patients with BECTS and controls, but 
the differences between BECTS and control groups appear static over the first two years 
after diagnosis. In contrast, brain developmental changes are heterogeneous and include 
slowing of normal neurodevelopmental processes (thinning) and alterations of subcortical 
structures. Though cortical and subcortical development in children with BECTS is quite 
different from controls, their ultimate course remains to be determined. Also, it should be 
noticed that seizure-remission status did not drive our findings; therefore, differences 
between BECTS patients and controls are unlikely due to the seizure-related factors 
examined here. Whether neurodevelopmental processes normalize and “catch up” after 
seizure remission and termination of AEDs, or whether participants with BECTS recover 
from their syndrome with static and stable cognitive and neuroanatomical differences, are 
questions for future prospective studies.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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KEY POINTS
• Both groups exhibited cognitive development over the two-year period, but 
BECTS continued to perform below controls in a static fashion.
• Close to the time of diagnosis, children with BECTS exhibited regions of 
thinner cortex in the frontal, temporal, and occipital lobes.
• Over the two years after epilepsy diagnosis, children with BECTS demonstrated 
restricted regions of both cortical thinning and thickening.
• Children with BECTS demonstrated atypical baseline and prospective 
volumetric changes in the putamen.
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Figure 1. Prospective change in neuropsychological assessment in BECTS and control 
participants
Cognitive results for children with BECTS compared to control participants (HC) in (A) 
confrontation naming (BNT), (B) immediate verbal memory (CMS), and motor function: 
(C) Grooved Pegboard and (D) WISC-III Coding. These four tests showed main effects for 
Group in which, evidently, the group of BECTS were lower than HC in all of them. None of 
these tests showed main effects for Time. Analyses were corrected for age and gender.
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Figure 2. Thickness differences at baseline between BECTS and controls
Areas of thinner cortex identified at baseline by a whole brain vertex-wise analysis. Regions 
of thinner cortex in BECTS compared to healthy controls (HC) are shown for the left and 
right hemispheres. The color of the scale bar indicates the statistical significance of the 
clusters corrected for multiple comparisons. Blue-cyan represents thinner cortex in the 
BECTS group compared to HC. Cluster-wise corrected at p<0.05. Corrected for age and 
gender.
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Figure 3. Prospective change in cortical thickness for each group
Areas of cortical thickness change identified by whole brain vertex-wise analysis in BECTS 
(A) and healthy controls (HC) (B). The color of the scale bar indicates the statistical 
significance of the clusters. Blue-cyan represents cortical thinning; red represents cortical 
thickening. Cluster-wise corrected for multiple comparisons at p<0.05. Corrected for 
baseline differences in cortical thickness, age and gender.
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Figure 4. Comparison of prospective cortical thickness between BECTS and controls
Areas of reduced cortical thinning in the BECTS group compared to controls (HC) identified 
by whole brain vertex-wise analysis in left and right hemispheres. The color of the scale bar 
indicates the statistical significance of the clusters. Cluster-wise corrected for multiple 
comparisons at p<0.05. Corrected for baseline differences in cortical thickness, age and 
gender.
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Table 1
Demographic characteristics of participants
All participants BECTS (n=24) HC (n=41)
Age at baseline (mean±SD)a,c 10.5 ± 1.7 11.2 ± 1.8
Sex (F/M)a,c 11/13 19/22
Grade level (mean±SD)a,c 4.3 ± 1.7 5.1 ± 1.8
Parent education (mean±SD)a,c,f 4.2 ± 1.4 4.4 ± 1.5
IQ (mean±SD)b,c,f 103.3 ± 14.3 110.0 ± 9.7
AED (yes/no)c 15/9 -
Duration of BECTS (months: mean±SD)c,d 7.8 ± 3.7 -
Seizure-free at follow-up (yes/no)c 10/14 -
Participants with imaging data BECTS (n=13) HC (n=24)
Age at baseline (mean±SD)a 10.3 ± 1.9 11.3 ± 2.0
Sex (F/M)a 6/7 13/11
Grade level (mean±SD)a 4.2 ± 2.0 5.0 ± 1.9
Parent education (mean±SD)a,c,g 4.2 ± 1.3 4.4 ± 1.6
IQ (mean±SD)a,c,g 104.5 ± 15.1 107.8 ± 12.2
AED (yes/no)c 8/5 -
Duration of BECTS (months: mean±SD) c,e 6.5 ± 3.4 -
Seizure free at follow-up (yes/no)c 5/8 -
AED: antiepileptic drug; F: female; M: male; SD: standard deviation.
aNo significant differences between BECTS and Controls;
bSignificant differences between BECTS and Controls;
cNo significant differences between 24 BECTS and BECTS with imaging data;
dNo significant differences between 24 seizure-free and non-seizure-free BECTS;
eNo significant differences between 13 seizure-free and non-seizure-free BECTS;
fSignificant differences between 24 seizure-free and non-seizure-free BECTS;
gSignificant differences between 13 seizure-free and non-seizure-free BECTS.
Parent education: 1= <high school, 2=GED/HSED, 3=high school, 4=associates degree/trade school, 5=some college, 6=college graduate, 
7=master’s degree, 8=master’s +
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